Skip to main content
Clinical Trials/IRCT20210515051296N1
IRCT20210515051296N1
Recruiting
Phase 3

The effect of cupping therapy on blood oxygen level in patients with coronavirus 2 (SARS-CoV-2) infection with pulmonary involvement

Qazvin University of Medical Sciences0 sites55 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Qazvin University of Medical Sciences
Enrollment
55
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18 to 65 years
  • Resident of Qazvin
  • Willingness to participate in the research project and complete the consent form
  • Presence of typical evidence on lung CT\-Scan or positive specific RT\-PCR test from oropharyngeal secretions
  • Presence of clinical criteria for hospitalization (fever above 38 ° C or severe cough or shortness of breath or respiratory rate greater than 24 per minute or oxygen saturation less than 93%)

Exclusion Criteria

  • Having a history of coagulation diseases, obesity, deep vein thrombosis
  • Have a history of vertebral fracture or disc herniation
  • Patients during pregnancy, lactation, and menstruation
  • Patients with heart failure
  • Patients with chronic renal failure
  • cancer patients
  • Patients with defective immune system or Patients receiving corticosteroids
  • Existence of open wound at the site of cupping

Outcomes

Primary Outcomes

Not specified

Similar Trials